|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 358.50 EUR | -1.51% |
|
-0.14% | +0.28% |
| 12-18 | French and Benelux stocks-Factors to watch | RE |
| 12-18 | Virbac acquires Felanorm in a deal valued at 100 million pounds | RE |
| Capitalization | 3.05B 3.55B 2.84B 2.65B 4.93B 320B 5.31B 32.68B 12.85B 153B 13.3B 13.03B 561B | P/E ratio 2025 * |
19.6x | P/E ratio 2026 * | 17.6x |
|---|---|---|---|---|---|
| Enterprise value | 3.14B 3.65B 2.93B 2.72B 5.07B 329B 5.46B 33.62B 13.22B 157B 13.69B 13.4B 577B | EV / Sales 2025 * |
2.14x | EV / Sales 2026 * | 1.98x |
| Free-Float |
47.73% | Yield 2025 * |
0.43% | Yield 2026 * | 0.48% |
Last Transcript: Virbac
| 1 day | -1.51% | ||
| 1 week | -0.14% | ||
| Current month | +0.28% | ||
| 1 month | +5.75% | ||
| 3 months | +13.99% | ||
| 6 months | +4.98% | ||
| Current year | +0.28% |
| 1 week | 348.5 |  | 367 |
| 1 month | 338 | | 367 |
| Current year | 348.5 | | 367 |
| 1 year | 249.7 | | 371.5 |
| 3 years | 232.5 | | 400 |
| 5 years | 200.5 | | 448.5 |
| 10 years | 102.1 | | 448.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sophie Favini
COO | Chief Operating Officer | - | 01/07/2023 |
| Chief Tech/Sci/R&D Officer | - | 01/01/2021 | |
Michel Garaudet
DFI | Director of Finance/CFO | 71 | 27/07/2010 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 61 | 01/04/2006 | |
Philippe Capron
BRD | Director/Board Member | 66 | 28/07/2010 |
| Director/Board Member | 65 | 05/09/2017 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.51% | -0.14% | +14.17% | +43.98% | 3.55B | |
| -0.65% | -2.10% | -23.85% | -20.80% | 56.04B | |
| -0.21% | +2.00% | +100.94% | +77.84% | 11.66B | |
| +0.33% | +1.90% | -21.55% | +8.17% | 4.02B | |
| -1.21% | +14.07% | +169.86% | +67.54% | 2.73B | |
| -0.12% | +8.27% | -13.04% | +9.58% | 1.87B | |
| +0.80% | +3.62% | +96.15% | +170.11% | 1.6B | |
| +1.12% | +6.02% | +13.91% | +4.68% | 1.3B | |
| -1.15% | +0.12% | +20.82% | -11.99% | 1.19B | |
| -0.37% | +2.54% | +31.43% | -35.18% | 1.19B | |
| Average | -0.28% | +3.34% | +38.88% | +31.39% | 8.51B | |
| Weighted average by Cap. | -0.51% | +1.90% | +5.60% | +4.17% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 1.46B 1.7B 1.37B 1.27B 2.37B 154B 2.55B 15.69B 6.17B 73.47B 6.39B 6.26B 269B | 1.54B 1.79B 1.44B 1.34B 2.49B 162B 2.68B 16.51B 6.49B 77.32B 6.72B 6.58B 283B |
| Net income | 157M 183M 146M 136M 254M 16.47B 273M 1.68B 661M 7.88B 685M 671M 28.86B | 175M 203M 163M 151M 282M 18.32B 304M 1.87B 735M 8.76B 762M 746M 32.1B |
| Net Debt | 87.8M 102M 81.87M 76.18M 142M 9.21B 153M 941M 370M 4.41B 383M 375M 16.14B | -1.3M -1.52M -1.22M -1.13M -2.11M -137M -2.27M -13.97M -5.49M -65.42M -5.69M -5.57M -240M |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/01/26 | 358.50 € | -1.51% | 3,932 |
| 09/01/26 | 364.00 € | +0.69% | 3,018 |
| 08/01/26 | 361.50 € | +0.70% | 1,914 |
| 07/01/26 | 359.00 € | +0.98% | 4,653 |
| 06/01/26 | 355.50 € | -0.97% | 6,016 |
Real-time Euronext Paris, January 12, 2026 at 07:55 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- VIRP Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition